Review about approved drugs
Posted: Thu Nov 21, 2024 8:19 am
Understanding Multiple Sclerosis Pathophysiology and Current Disease-Modifying Therapies
https://www.imrpress.com/journal/FBL/29 ... 911386/htm
MS is an incurable disease; however, since the introduction of interferon (IFN) in 1993, there has been a significant increase in the number of treatment options available to MS patients [5]. Currently, there are more than 19 United States Food and Drug Administration (FDA)- and European Medicines Agency (EMA)-approved disease modifying therapies (DMTs) available to treat patients with MS, each targeting specific immunological mechanisms (Tables 1,2,3,4) [6, 7]. However, the existence of multiple DMTs for MS treatment, coupled with variations in international guidelines, has led to inconsistent decision-making across clinics, raising concern and requiring attention [7, 8, 9, 10].
[Free full text]
https://www.imrpress.com/journal/FBL/29 ... 911386/htm
MS is an incurable disease; however, since the introduction of interferon (IFN) in 1993, there has been a significant increase in the number of treatment options available to MS patients [5]. Currently, there are more than 19 United States Food and Drug Administration (FDA)- and European Medicines Agency (EMA)-approved disease modifying therapies (DMTs) available to treat patients with MS, each targeting specific immunological mechanisms (Tables 1,2,3,4) [6, 7]. However, the existence of multiple DMTs for MS treatment, coupled with variations in international guidelines, has led to inconsistent decision-making across clinics, raising concern and requiring attention [7, 8, 9, 10].
[Free full text]